Potentially Life-Threatening Interactions Between Newer...
August 1, 2021 - Featured , In the News / Politics By: Richa Tamakuwala, PharmD Candidate c/o 2022 There has been a dramatic rise in the number of patients with cardiovascular implantable electronic devices (CIEDs), such as permanent pacemakers and implantable cardioverter‐defibrillators (ICDs), due to an increasing aging population and clinical trials showing benefits in mortality and morbidity. Multiple studies investigating the use of ICDs… |
|
Pharmaceutical Breakthrough for the Treatment of Duchen...
June 1, 2021 - Featured , In the News / Politics By: Rubab Hassan, PharmD Candidate c/o 2022 Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration and weakness along with various other symptoms. It is predominantly caused by deletions of one or more exons, which lead to mutations of the dystrophin gene. Dystrophin stops muscle fibers from being degraded by proteases.… |
|
Desmopressin Challenge for Von Willebrand’s Disease i...
June 1, 2021 - Featured , In the News / Politics By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences A patient with past medical history of von Willebrand’s disease (VWD) and myasthenia gravis on chronic prednisone therapy, presented for follow-up for VWD at the hematology/oncology clinic. The provider considered having the patient undergo a “desmopressin challenge” with desmopressin… |
|
Correlation of Salt-Intake and Hypertension...
June 1, 2021 - Featured , In the News / Politics By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022 While the focus over the last year has been fixated on the deadly coronavirus, the importance of a long-standing health pandemic exacerbated by salt intake cannot be overlooked. Hypertension, more commonly referred to as high blood pressure, is a medical… |
|
FDA approves Vibegron (Gemtesa®) for the Treatment of ...
June 1, 2021 - Featured , In the News / Politics By: Arya Firoozan, PharmD Candidate c/o 2023 Overactive bladder (OAB) is a condition that causes a sudden and frequent urge to urinate. It is also associated with incontinence and nocturia. Nocturia refers to waking up at night due to the urge to urinate. OAB is diagnosed if there is no other current infection or… |
|
Connecting the Dots: Ankylosing Spondylitis and Heart D...
June 1, 2021 - Featured , In the News / Politics By: Jennifer Galvet, PharmD Candidate c/o 2024 Ankylosing spondylitis (AS) is a systemic inflammatory condition that primarily affects a person’s back.¹ It is a form of arthritis that affects the spine and causes inflammation of the spinal joints, leading to severe, chronic pain and discomfort.² Ankylosing spondylitis can also impact other areas of the… |
|
Bamlanivimab for the treatment of COVID-19...
April 1, 2021 - Featured , In the News / Politics By: Daniela Farzadfar, PharmD,PGY-1 Resident at Long Island Jewish Medical Center In March 2020, the World Health Organization (WHO) declared coronavirus disease- 2019 (COVID-19) a global pandemic. 1 To date, over 30 million cases of COVID-19 have been reported in the United States and drug companies have been scrambling to develop therapies for the… |
|
Insulin Monitoring System for Pediatric patients...
April 1, 2021 - Featured , In the News / Politics By: Lyana Sayilar, PharmD Candidate c/o 2022 On August 31, 2020, the FDA approved the first automated diabetes management device for patients aged 2 to 6-years old. The MiniMed 770G System automatically adjusts basal insulin doses based on glucose levels, facilitating the lives of the patient and caregiver. Prior to its approval, patients and/or… |
|
Who is COVID-19 hitting the hardest?...
April 1, 2021 - Featured , In the News / Politics By: Pooja Dasgupta and Sonya Wadhawan, PharmD Candidates c/o 2025 The coronavirus, also known as SARS CoV-2 or COVID-19, has widely affected various people globally. The study of SARS CoV-2 has shifted from studying individuals and their unique symptoms during their disease duration to studying different populations and their backgrounds that increase the risk… |
|
Fostemsavir: New drug for the treatment of HIV-1 resist...
April 1, 2021 - Featured , In the News / Politics By: Bisma Sekhery, PharmD Candidate c/o 2021 Fostemsavir (Rukobia) is a new Food and Drug Administration (FDA) approved antiretroviral agent for the treatment of Human Immunodeficiency Virus (HIV). It was approved in July 2020 for multidrug-resistant HIV-1. It is a pro-drug, metabolized to its active moiety, temsavir, which binds to the gp120 subunit within… |
|
AstraZeneca Sells Rights to Two Cardiovascular Drugs fo...
April 1, 2021 - Featured , In the News / Politics By: Jennifer Galvet, PharmD Candidate c/o 2024 Introduction The British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has agreed to sell its rights to two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million. This decision allows AstraZeneca to reinvest in the company’s main areas of focus: cardiovascular, renal and metabolism, cancer, respiratory, inflammation and… |
|
Daniel Schneider RPh.’s crusade against OxyContin...
February 1, 2021 - Featured , In the News / Politics By: Alisha Kuriakose, PharmD Candidate c/o 2022 “The Pharmacist” is a Netflix documentary that showcases pharmacist Dr. Daniel Schneider’s crusade against OxyContin® abuse. It highlights his discovery of a corrupt doctor who exploited her medical license and destroyed communities in Louisiana. It also illustrates his fight to expose Purdue Pharma of falsely reporting the addictive… |
|
EndeavourRx ™: The Prescription-Only, FDA-Approved Vi...
February 1, 2021 - Featured , In the News / Politics By: Aiśa Mrkulic PharmD Candidate c/o 2022 Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common reasons children require referrals for mental health services.¹ In fact, the American Academy of Pediatrics (AAP) recommends the screening of every child with ADHD for neuropsychiatric comorbidities. With, “one in every 20 children affected,” it exists… |
|
FDA Approves GlaxoSmithKline’s Combined Formulation o...
February 1, 2021 - Featured , In the News / Politics By: Edwin Gruda, PharmD Candidate c/o 2022; Aiśa Mrkulic, PharmD. Candidate c/o 2022 Over-the-Counter (OTC) medications are typically used for mild pain relief. Many patients rely on their OTC medications to treat headaches, fevers, muscle pain, tooth aches and mild arthritis. In March of 2020, the Food and Drug Administration (FDA) approved a new… |
|
NMOSD Treatment...
February 1, 2021 - Featured , In the News / Politics By: Lyana Sayilar PharmD. Candidate c/o 2022 Neuromyelitis optica spectrum disorder (NMOSD) is a rare disorder affecting 4,000 to 8,000 Americans. Adults with this disorder are often found to have anti-aquaporin-4 (AQP4)antibodies that primarily attack healthy cells and proteins in the optic nerves and spinal cord. The majority of patients have relapses within three… |
|
Flu Shot Season, COVID-19 and How Pharmacies are Bracin...
February 1, 2021 - Featured , In the News / Politics By: Rebecca Samuel, PharmD Candidate c/o 2022 and Pallak Sharma, PharmD Candidate c/o 2022 It is flu shot season! That’s a phrase that causes almost every pharmacy staff member to take a deep breath. Amid the pandemic, flu shot season is busier than ever and it is directly affecting pharmacies across the country. In… |
|
MIS-C: The Impact of COVID-19 on the Pediatric Populati...
December 1, 2020 - Featured , In the News / Politics By: Erica Tonti, PharmD Candidate c/o 2022 Multisystem Inflammatory Syndrome in Children, or MIS-C, is a recent syndrome recognized by the Centers for Disease Control and Prevention (CDC). The emergent outbreak of COVID-19 brought concern as to who would be affected by MIS-C and how severe the impact of the syndrome would be. Children, thought to… |
|
Next Up in the World of Hyperlipidemia: Nexletlol TM...
December 1, 2020 - Featured , In the News / Politics By: Preethi Samuel, Pharm.D. Candidate c/o of 2021 In the United States, at least one person has a heart attack every 40 seconds and 1 of every 5 is silent.1 Heart attacks are commonly a result of atherosclerotic cardiovascular disease (ASCVD). Preceding plaque buildup in arterial walls can potentially lead to a heart attack… |
|
A New Drug Class for Heart Failure—Dapagliflozin’s ...
December 1, 2020 - Featured , In the News / Politics By: Adrian Wong, PharmD Candidate c/o 2021 On May 5, 2020, the Food and Drug Administration (FDA) announced its approval for Farxiga® (dapagliflozin) oral tablets to have a new indication: to lower the risk of cardiovascular death and hospitalization for adults with New York Heart Association (NYHA) functional class II-IV heart failure (HF) with reduced… |
|
Provider Status: What is it?...
October 1, 2020 - Featured , In the News / Politics By: Katharine Russo, PharmD Candidate c/o 2021 As of July 1, 2000, the Accreditation Council for Pharmacy Education (ACPE) mandated for the Doctor of Pharmacy (PharmD) degree to be the sole degree required to enter pharmacy practice in the United States. ¹ With this advanced degree came the complex education, training, and clinical practice… |
|
The Psychological impact of COVID-19 on Mental Health &...
October 1, 2020 - Featured , In the News / Politics By: Shea Dorsey, PharmD Candidate c/o 2021 COVID-19 has taken a major toll on the mental wellbeing of people around the world and continues to do so today, almost 7 months after the United States first announced quarantine. Many individuals previously diagnosed with an anxiety disorder, depressive disorder, trauma-and stressor-related disorder (TSRD) or expressed… |
|
New York State and Provider Status...
October 1, 2020 - Featured , In the News / Politics By: Mah Noor, PharmD Candidate c/o 2021 Over the past decade, pharmacists across the nation have joined in a number of grassroots efforts to gain legislative recognition as health care providers. As of 2019, thirty-four states have recognized pharmacists as providers in at least one section of their state statute or in their state… |
|
The State of Pharmacy Advocacy in New York...
October 1, 2020 - Featured , In the News / Politics By: Jeremy Mesias, PharmD Candidate c/o 2022 As we begin another October, we mark the start of American Pharmacist Month and celebrate pharmacists and their work around the country. We are also reminded of the great leaps and bounds our profession has made over the years to advance patient care. Behind all great progress,… |
|
Metastatic Breast CancER+ Treatment...
August 1, 2020 - Featured , In the News / Politics By: Lyana Sayilar, PharmD Candidate c/o 2020 Approved on April 17, 2020, tucatinib (TukysaTM) is indicated to aid in the treatment of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer and could be a potential add-on therapy.3 Among the different types of breast cancers, an increase of HER2, a transmembrane glycoprotein consisting… |
|
COVID-19 and the vaccine development process: A closer ...
August 1, 2020 - Featured , In the News / Politics By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain responsible for causing COVID-19, continues to have a profound impact on communities at a local, national and global level. As of August 20, 2020, nearly 5.7 million confirmed cases exist in the United States with a total of… |
|
When Epidemic Meets Pandemic: Treatment of Opioid Use D...
June 1, 2020 - Featured , In the News / Politics By: Preethi Samuel, PharmD Candidate c/o 2021, Aisa Mrkulic, PharmD. Candidate c/o 2022 Opioid use disorder (OUD) is a chronic illness involving misuse of opioids, both prescribed and non-prescribed, as well as the use of illicitly obtained heroin. OUD carries a risk of fatal overdose, preceded by the following triad: pinpoint pupils, respiratory depression,… |
|
Dexamethasone and COVID-19...
June 1, 2020 - Featured , In the News / Politics By: Natalia Loomis, PharmD Candidate c/o 2022 The World Health Organization announced the official name “COVID-19” on February 11, 2020 when the outbreak was first identified in Wuhan, China. ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease and 19 for the year the first case occurred.2 The Center for Disease Control and… |
|
NIH COVID-19 Treatment Guidelines Update: remdesivir, c...
June 1, 2020 - Featured , In the News / Politics By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome 2 (Sars-Cov-2), the viral strain responsible for causing COVID-19, continues to have an undeniable impact both on a national level and a global level. As of June 20th, 2020, there have been nearly 2.4 million reported cases in the United States, with nearly 122,000… |
|
Brexanolone (Zulresso™) in the treatment of Postpartu...
April 1, 2020 - Featured , In the News / Politics By: Shivani Kaneria, Pharm D. Candidate c/o 2020 Postpartum depression is a mood disorder that affects 10 – 20 percent of new mothers post childbirth per year, and is caused by a combination of both physical and emotional factors.5 Mothers who experience this form of depression undergo common symptoms of feeling sad, crying often with… |
|
All Hearts Matter!...
April 1, 2020 - Featured , In the News / Politics By: Aiśa Mrkulic, PharmD. Candidate c/o 2022 APhA’s Red Dress Gala continues to be their largest, not-for-profit fundraising event of the year. Welcome were members and non-members all the same. Student pharmacists from other chapters are often present—the 5th Annual Red Dress Gala being no exception! DAC Ballroom housed the festivities, as awareness was brought… |
|
Suffering from migraines? Eptinezumab-jjmr (Vyepti™) ...
April 1, 2020 - Featured , In the News / Politics By: Alisha Kuriakose, PharmD Candidate c/o 2022 Every ten seconds, someone in the United States (U.S.) goes to the emergency room with complaints of head pain, many of which can be attributed to migraines. A migraine is a neurological condition characterized by intense and debilitating headaches. Those suffering from migraines may have experiences including nausea,… |
|
Combating the neglected consequences of the opioid cris...
February 1, 2020 - Featured , In the News / Politics By: Mah Noor, PharmD Candidate c/o 2021 Although the opioid crisis began in the late 1990s, there has been a recent increase in prescription and illicit opioid drug use which has led to an increased prevalence of opioid overdoses due to misuse and dependency. In 2017, the number of overdose related deaths involving opioids, including… |
|
COVID-19: The 2019 novel coronavirus...
February 1, 2020 - Featured , In the News / Politics By: Darien Lee, PharmD Candidate c/o 2021 Wuhan, the most populous city in Central China, has a population of over 11 million people. The city is one of China’s largest transportation and manufacturing centers with dozens of railways and roads as well as thousands of technological enterprises and institutions, respectively. In late December 2019,… |
|
FDA approves romosozumab (Evenity®) for the treatment ...
December 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 Osteoporosis is a bone disease affecting nearly ten million people in the United States.1 It can be caused by excess bone loss, insufficient bone production, or a combination of both factors. The disease is responsible for two million broken bones and 19 billion dollars in related healthcare… |
|
Food and Drug Administration approves lofexidine (Lucem...
October 1, 2019 - Featured , In the News / Politics By: Evanthia Siozios, PharmD Candidate c/o 2020 Anxiety, nausea, muscle pain, insomnia are some of the most common withdrawal symptoms experienced when users stop taking opioids. According to a randomized controlled trial entitled Prescription Opioid Addiction Treatment Study (POATS) conducted in outpatient treatment settings across the United States including Mclean Hospital in Massachusetts and… |
|
The rising cost of insulin...
October 1, 2019 - Featured , In the News / Politics By: Daniela Farzadfar, PharmD Candidate c/o 2020 Over 30 million Americans are currently living with diabetes. According to the American Diabetes Association (ADA), in 2017, the total cost of diagnosed diabetes in the United States was 327 billion dollars with 237 billion dollars alone attributed to direct medical costs.1 Among these direct medical costs… |
|
The “Netflix” approach to hepatitis C drugs...
August 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 In a February 2019 Senate Finance Committee hearing, executives from major pharmaceutical companies including AbbVie, Merck, and AstraZeneca were criticized for the high cost of brand-name prescription drugs.1 When asked why brand-name prescription drugs in the United States were more expensive compared to other developed countries, an… |
|
Bridging medicine and technology: FDA approves first di...
August 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 As modern technology continues to grow ever more complex and powerful, it is no surprise that the healthcare industry is constantly searching for medical applications of the latest technological advancements. Whether it be new health system software or medical devices for at home testing, the integration of… |
|
United States Department of Health and Human Services (...
June 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 In 2017, 70,237 overdose deaths occurred in the United States. Of those deaths, 47,600 (sixty-seven point eight percent of all drug overdose deaths in 2017) involved opioids.1 As the current main driver of drug overdose deaths, opioids and their misuse and abuse represent an ongoing health epidemic… |
|
Esketamine (Spravato™): a new treatment option for de...
June 1, 2019 - Featured , In the News / Politics By: Sylvia Hong (PharmD Candidate c/o 2021), Muaz Sadeia (PharmD Candidate c/o 2021) On March 5, 2019, Janssen Pharmaceuticals gained approval from the Food and Drug Administration (FDA) for esketamine (Spravato™), the first fast acting nasal spray antidepressant indicated for treatment of resistant depression as conjunctive therapy to oral antidepressants in adults.1 This new… |
|
Food and Drug Administration (FDA) approves patisiran (...
April 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 In the investigation of gene function and its role in health care and disease management, RNA interference is an important scientific tool. Possessing the ability to individually turn off nearly 22,000 genes upon introduction into human cells, small interfering ribonucleic acids (siRNAs), while useful in research settings,… |
|
The expanding role of the specialty pharmacy team in ca...
April 1, 2019 - Featured , In the News / Politics By: Vasantha Kolluri, PharmD Candidate c/o 2019 With the recent advancement of oral oncology drugs, there has been an ever-growing need for specialty pharmacy services. Although these oral agents allow for patients to receive therapy at home, clinical outcomes heavily depend upon patient adherence and management. Specialty pharmacy is a niche area of pharmacy practice… |
|
Challenging the stigma of mental health...
February 1, 2019 - Featured , In the News / Politics By: Mah Noor, PharmD Candidate c/o 2021 As society flourishes, life seems to grow more complex. Among the barrage of images, voices and social media campaigns, a domestic issue which often seems to be neglected in the United States is the overall deficit in addressing various aspects of mental health. On May 30, 2018 The… |
|
Food and Drug Administration (FDA) approves baloxavir m...
December 1, 2018 - Featured , In the News / Politics By: Ruchira Kasbekar, PharmD Candidate c/o 2020 It is estimated that approximately 80,000 Americans died from the flu during the 2017-2018 flu season which is the highest death toll from influenza in the last four decades.1 As the 2017-2018 flu season progressed, there was a shortage of oseltamivir (Tamiflu®) availability. To prevent shortages during the… |
|
Fingolimod’s (Gilenya®) expanding role in the treatm...
December 1, 2018 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 In 2010, the Food and Drug Administration (FDA) approved fingolimod (Gilenya®) for the treatment of adults with relapsing multiple sclerosis (MS).1 Historically, fingolimod has been used as a convenient second line oral treatment upon failure of initial disease-modifying therapy for relapsing-remitting MS in adult populations.2 Therefore, when a… |
|
Food and Drug Administration (FDA) announces additional...
October 10, 2018 - Featured , In the News / Politics By: Karen Chen, PharmD Candidate c/o 2019 On July 13th, 2018, the U.S. Food and Drug Administration (FDA) announced a voluntary recall of several different national drug codes (NDCs) of medications containing the active ingredient valsartan (Diovan®) after the discovery of an impurity called N-nitrosodimethylamine (NDMA). The reason for the recall was because the impurity… |
|
Innovation and internet outreach: ...
October 1, 2018 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 As the nation continues to struggle with the growing opioid epidemic, numerous organizations, researchers, and even the president are taking initiative in resolving the crisis. Of these groups, perhaps one of the most proactive in its efforts is the Food and Drug Administration (FDA). With its promotion of… |
|
Food and Drug Administration (FDA) warning about biotin...
August 1, 2018 - Featured , In the News / Politics By: Rizwan Atiq, PharmD Candidate c/o 2019 – Biotin is a nutrient that is present in certain foods and is available as a dietary supplement. It is present in many multivitamins as well as sold as its own supplement in pharmacies and supermarkets. It is marketed as a vitamin which is used to improve the… |
|
Food and Drug Administration (FDA) approves Cassipa®: ...
August 1, 2018 - Featured , In the News / Politics By: Maria Spilios, PharmD Candidate c/o 2019 – Opioid dependence is a major public health concern. Misuse of prescription opioids and heroin affects more than two million Americans and an estimated fifteen million people worldwide per year; the prevalence of misuse and addiction is rapidly increasing with each passing year. More than 20,000 deaths in… |
|
Concierge pharmacy practice: RxVIP and your future...
August 1, 2018 - Featured , In the News / Politics By: Lameesa Dhanani, PharmD Candidate c/o 2019 – *Disclaimer: In November 2018, the FDA issued a Safety Communication against changing a patient’s medications solely based on the genetic test results since these genetic tests have not been reviewed by the FDA. In a competitive market where pharmacy jobs are scarce, I always remind myself why… |